Articles Tagged With: bacteria
-
New Study: Hospital Surfaces Contaminated After Disinfection
Pathogenic persistence can be a problem even after routine disinfection of high-touch surfaces.
-
Incentivizing New Antibiotics to Kill Multidrug-Resistant Bugs
Bacteria have developed resistance to so many antibiotics that a familiar adage about these lifesaving drugs is “use ’em and lose ’em.” Ideas to break this cycle and create a market for new antibiotics include the proposed PASTEUR (Pioneering Antimicrobial Subscriptions To End Upsurging Resistance) Act of 2023, which has been reintroduced in Congress.
-
Burning Down the House: Climate Change Drives Emerging Infections
The connection between emerging infections and climate change has gone from theoretical discussions in the past few years to an evidence-based phenomenon happening in real time. That said, there are multiple converging factors, and attributing all emerging infections to global warming is too broad a stroke to explain a complex issue.
-
CDC: Resistance Emerging to Last-Line Carbapenem Drugs
Carbapenems are a last-line antibiotic, one of the final weapons in the formulary against multidrug-resistant bacteria. But the ever-evolving bugs are starting to solve this drug class and have found an ingenious way to do it — genetic transfer of resistant properties to another Gram-negative bacterium.
-
Bacteriophages: Strange Viruses that Eat Bacteria for Breakfast
For an American couple, it began with a dream trip to the Valley of the Kings in Egypt. It turned into the curse of the pharaohs. The husband developed a pan-resistant Gram-negative infection that turned septic.
-
Caring for Young Febrile Infants
Every clinician has struggled with managing a febrile infant. We know the majority will have a benign viral illness, but we fear the serious bacterial infection that may have devastating consequences in this vulnerable population. This evidence-based article reviews the current literature and approach to infants less than 60 days of age.
-
Gut Microbiome in Patients at Risk for Parkinson’s Disease
Certain risk factors and prodromal markers of Parkinson’s disease (PD), such as constipation and rapid eye movement sleep behavior disorder, are associated with specific bacterial compositions of the gut. However, the value of gut microbiome data to predict the risk of PD development needs further investigation.
-
Should Metronidazole Be Added Routinely to Treatment Regimens for PID?
This randomized, double-blind, placebo-controlled trial compared ceftriaxone (250 mg intramuscular once) and doxycycline (100 mg orally twice per day for 14 days) with and without metronidazole (500 mg orally twice per day for 14 days) for the treatment of pelvic inflammatory disease.
-
Gut Microbiome in Patients at Risk for Parkinson’s Disease
Certain risk factors and prodromal markers of Parkinson’s disease (PD), such as constipation and rapid eye movement sleep behavior disorder, are associated with specific bacterial compositions of the gut. However, the value of gut microbiome data to predict the risk of PD development needs further investigation.
-
A New Treatment for Recurrent Bacterial Vaginosis?
In this randomized controlled trial of 228 women, Lactobacillus crispatus CTV-05 (Lactin-V) applied vaginally for 11 weeks reduced the incidence of recurrent bacterial vaginosis from 45% in the placebo arm to 30% in the Lactin-V arm.